Change in psychosocial functioning and depressive symptoms during acute-phase cognitive therapy for depression.

Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry (2013) 1.77

A prospective study of perinatal depression and trauma history in pregnant minority adolescents. Am J Obstet Gynecol (2012) 0.91

Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry (2014) 0.89

Nomothetic and idiographic symptom change trajectories in acute-phase cognitive therapy for recurrent depression. J Consult Clin Psychol (2013) 0.89

Are Improvements in Cognitive Content and Depressive Symptoms Correlates or Mediators during Acute-Phase Cognitive Therapy for Recurrent Major Depressive Disorder? Int J Cogn Ther (2014) 0.79

Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder. J Affect Disord (2014) 0.77

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients. PLoS One (2016) 0.76

Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors. Hum Psychopharmacol (2015) 0.76

Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder. J Affect Disord (2016) 0.75

Longitudinal changes in somatic symptoms and family disagreements among depression and community groups: a 23-year study. BMC Psychiatry (2015) 0.75

The relationship between symptom relief and psychosocial functional improvement during acute electroconvulsive therapy for patients with major depressive disorder. Int J Neuropsychopharmacol (2017) 0.75

A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89

An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61

Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 58.92

Missing data: our view of the state of the art. Psychol Methods (2002) 42.97

The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry (1987) 10.84

How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry (2001) 7.73

The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med (1996) 7.70

The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry (2003) 7.19

National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry (1989) 6.63

Assessment of social adjustment by patient self-report. Arch Gen Psychiatry (1976) 6.35

Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol (2006) 5.48

Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry (1995) 3.92

Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80

Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry (2005) 3.46

Treatments of depression and the functional capacity to work. Arch Gen Psychiatry (1992) 2.53

The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med (1999) 2.36

Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA (2003) 2.23

A comparison of three scales for assessing social functioning in primary care. Am J Psychiatry (2001) 2.18

Depression and public health: an overview. J Psychosom Res (2002) 2.18

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry (1998) 2.13

Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Arch Gen Psychiatry (1992) 1.79

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65

Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry (1992) 1.54

Cognitive-behavioral therapy for bulimia nervosa: time course and mechanisms of change. J Consult Clin Psychol (2002) 1.49

Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up. Contemp Clin Trials (2010) 1.26

Improvement in social-interpersonal functioning after cognitive therapy for recurrent depression. Psychol Med (2004) 1.11

Psychosocial functioning in the context of diagnosis: assessment and theoretical issues. Psychol Assess (2009) 1.08

Symptom-based predictors of a 10-year chronic course of treated depression. J Nerv Ment Dis (1999) 1.06

Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression. J Affect Disord (2008) 0.99

Mediators and moderators of change in cognitive therapy of depression. Psychol Bull (1993) 0.98

Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry (1998) 0.96

Continuation-phase cognitive therapy's effects on remission and recovery from depression. J Consult Clin Psychol (2009) 0.86

Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry (2003) 0.86

Social impairments four years after an acute depressive episode. Am J Orthopsychiatry (1977) 0.84

Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group. Psychopharmacol Bull (1996) 0.84

Social adjustment in depressed patients treated with venlafaxine and amitriptyline. Int Clin Psychopharmacol (2002) 0.83

Impairment of work and leisure in depressed outpatients. A preliminary communication. J Affect Disord (1986) 0.82

The process of change in Interpersonal Psychotherapy (IPT) for depression: a case study for the new IPT therapist. Psychiatry (2005) 0.77

The effects of venlafaxine on social activity level in depressed outpatients. J Clin Psychiatry (1999) 0.77